Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,401,850
+$322,041 QoQ
Shares Held
151,250
-1.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#238
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $12,369,158 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
54,446 | $3,912,489 | |
| 2 | VTRS |
Viatris Inc
This page
|
151,250 | $2,401,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,249 | $2,232,985 | |
| 4 | HROW |
Harrow, Inc.
|
22,430 | $952,602 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
37,614 | $925,680 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,447 | $784,027 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
12,639 | $587,838 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,310 | $383,100 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,401,850 | 151,250 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,079,809 | 153,946 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,897,379 | 152,400 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,425,332 | 143,973 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,304,172 | 146,044 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,365,431 | 156,766 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,960,999 | 157,510 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,871,113 | 161,164 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,659,554 | 156,120 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,853,409 | 155,227 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,632,762 | 150,763 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,506,489 | 152,788 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,561,569 | 156,470 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,612,609 | 167,631 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,873,267 | 168,308 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,447,539 | 169,899 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,797,468 | 171,678 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,985,643 | 182,504 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,527,822 | 186,831 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,750,229 | 202,969 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,446,590 | 241,189 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,591,085 | 257,057 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $5,278,944 | 281,694 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||